Biocept Inc (NASDAQ:BIOC) CEO Mike Nall tells Proactive the liquid biopsy test provider has struck up an agreement with an undisclosed independent physician association in California to provide liquid biopsy testing services to its physicians and patients. Nall says this is the first value-based delivery system partnership of its kind for Biocept. Nall also mentioned the company will soon be launching its cerebral spinal fluid liquid biopsy test.
Biocept pursuing new strategy with a physician association using its liquid biopsy cancer tests
Quick facts: Biocept Inc
Price: 5.12 USD
Market Cap: $68.59 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Biocept Inc named herein, including the promotion by the Company of Biocept Inc in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE